Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo controlled, crossover study

Jau Shin Lou, Greg Kearns, Theodore Benice, Barry Oken, Gary Sexton, John Nutt

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double-blind, placebo-controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Visit 1 or 2 and participated in the following two studies: (1) Finger tapping. Twenty-five PD patients used their index fingers to strike two keys 20 cm apart on a musical instrument digital interface (MIDI) keyboard. The slopes of the regression line of dwell time and movement time were used to assess the rate of fatigue development. (2) Force generation. Twelve PD patients contracted the wrist extensors maximally to obtain a baseline maximum voluntary contraction (BMVC) force. Then they repetitively contracted the wrist extensors at 50% of the BMVC for 7 seconds and rested for 3 seconds. An interval maximum voluntary contraction (IMVC) was measured every three repetitions. Fatigue was defined as an IMVC of less than 60% of the BMVC. The slope of the regression line of IMVC was used to assess the rate of force decline. These two studies were repeated 1 hour after carbidopa/levodopa (25/100) or placebo. Subjects filled out the Multidimensional Fatigue Inventory (MFI) at the beginning of the first visit. Results showed that the slope of dwell time decreased with levodopa but not with placebo (P = 0.004). The rate of force decline also decreased with levodopa but not with placebo (P = 0.01). The subscores in the dimension of physical fatigue in the MFI did not correlate with the rate changes in dwell time or the rate changes in force decline. We concluded that (1) levodopa improves physical fatigue in finger tapping and force generation, (2) physical fatigue in Parkinson's disease is at least partially related to dopamine deficiency, and (3) the MFI measures different aspects of physical fatigue compared with those measured by finger tapping and force generation.

Original languageEnglish (US)
Pages (from-to)1108-1114
Number of pages7
JournalMovement Disorders
Volume18
Issue number10
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

Levodopa
Cross-Over Studies
Fatigue
Parkinson Disease
Placebos
Fingers
Wrist
Equipment and Supplies
Dopamine

Keywords

  • Finger tapping
  • Force generation
  • MFI
  • MIDI
  • Parkinson's disease
  • Physical fatigue

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Levodopa improves physical fatigue in Parkinson's disease : A double-blind, placebo controlled, crossover study. / Lou, Jau Shin; Kearns, Greg; Benice, Theodore; Oken, Barry; Sexton, Gary; Nutt, John.

In: Movement Disorders, Vol. 18, No. 10, 10.2003, p. 1108-1114.

Research output: Contribution to journalArticle

Lou, Jau Shin ; Kearns, Greg ; Benice, Theodore ; Oken, Barry ; Sexton, Gary ; Nutt, John. / Levodopa improves physical fatigue in Parkinson's disease : A double-blind, placebo controlled, crossover study. In: Movement Disorders. 2003 ; Vol. 18, No. 10. pp. 1108-1114.
@article{1ce82220bb2940dcaf0da5633a251a84,
title = "Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo controlled, crossover study",
abstract = "We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double-blind, placebo-controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Visit 1 or 2 and participated in the following two studies: (1) Finger tapping. Twenty-five PD patients used their index fingers to strike two keys 20 cm apart on a musical instrument digital interface (MIDI) keyboard. The slopes of the regression line of dwell time and movement time were used to assess the rate of fatigue development. (2) Force generation. Twelve PD patients contracted the wrist extensors maximally to obtain a baseline maximum voluntary contraction (BMVC) force. Then they repetitively contracted the wrist extensors at 50{\%} of the BMVC for 7 seconds and rested for 3 seconds. An interval maximum voluntary contraction (IMVC) was measured every three repetitions. Fatigue was defined as an IMVC of less than 60{\%} of the BMVC. The slope of the regression line of IMVC was used to assess the rate of force decline. These two studies were repeated 1 hour after carbidopa/levodopa (25/100) or placebo. Subjects filled out the Multidimensional Fatigue Inventory (MFI) at the beginning of the first visit. Results showed that the slope of dwell time decreased with levodopa but not with placebo (P = 0.004). The rate of force decline also decreased with levodopa but not with placebo (P = 0.01). The subscores in the dimension of physical fatigue in the MFI did not correlate with the rate changes in dwell time or the rate changes in force decline. We concluded that (1) levodopa improves physical fatigue in finger tapping and force generation, (2) physical fatigue in Parkinson's disease is at least partially related to dopamine deficiency, and (3) the MFI measures different aspects of physical fatigue compared with those measured by finger tapping and force generation.",
keywords = "Finger tapping, Force generation, MFI, MIDI, Parkinson's disease, Physical fatigue",
author = "Lou, {Jau Shin} and Greg Kearns and Theodore Benice and Barry Oken and Gary Sexton and John Nutt",
year = "2003",
month = "10",
doi = "10.1002/mds.10505",
language = "English (US)",
volume = "18",
pages = "1108--1114",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Levodopa improves physical fatigue in Parkinson's disease

T2 - A double-blind, placebo controlled, crossover study

AU - Lou, Jau Shin

AU - Kearns, Greg

AU - Benice, Theodore

AU - Oken, Barry

AU - Sexton, Gary

AU - Nutt, John

PY - 2003/10

Y1 - 2003/10

N2 - We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double-blind, placebo-controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Visit 1 or 2 and participated in the following two studies: (1) Finger tapping. Twenty-five PD patients used their index fingers to strike two keys 20 cm apart on a musical instrument digital interface (MIDI) keyboard. The slopes of the regression line of dwell time and movement time were used to assess the rate of fatigue development. (2) Force generation. Twelve PD patients contracted the wrist extensors maximally to obtain a baseline maximum voluntary contraction (BMVC) force. Then they repetitively contracted the wrist extensors at 50% of the BMVC for 7 seconds and rested for 3 seconds. An interval maximum voluntary contraction (IMVC) was measured every three repetitions. Fatigue was defined as an IMVC of less than 60% of the BMVC. The slope of the regression line of IMVC was used to assess the rate of force decline. These two studies were repeated 1 hour after carbidopa/levodopa (25/100) or placebo. Subjects filled out the Multidimensional Fatigue Inventory (MFI) at the beginning of the first visit. Results showed that the slope of dwell time decreased with levodopa but not with placebo (P = 0.004). The rate of force decline also decreased with levodopa but not with placebo (P = 0.01). The subscores in the dimension of physical fatigue in the MFI did not correlate with the rate changes in dwell time or the rate changes in force decline. We concluded that (1) levodopa improves physical fatigue in finger tapping and force generation, (2) physical fatigue in Parkinson's disease is at least partially related to dopamine deficiency, and (3) the MFI measures different aspects of physical fatigue compared with those measured by finger tapping and force generation.

AB - We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double-blind, placebo-controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Visit 1 or 2 and participated in the following two studies: (1) Finger tapping. Twenty-five PD patients used their index fingers to strike two keys 20 cm apart on a musical instrument digital interface (MIDI) keyboard. The slopes of the regression line of dwell time and movement time were used to assess the rate of fatigue development. (2) Force generation. Twelve PD patients contracted the wrist extensors maximally to obtain a baseline maximum voluntary contraction (BMVC) force. Then they repetitively contracted the wrist extensors at 50% of the BMVC for 7 seconds and rested for 3 seconds. An interval maximum voluntary contraction (IMVC) was measured every three repetitions. Fatigue was defined as an IMVC of less than 60% of the BMVC. The slope of the regression line of IMVC was used to assess the rate of force decline. These two studies were repeated 1 hour after carbidopa/levodopa (25/100) or placebo. Subjects filled out the Multidimensional Fatigue Inventory (MFI) at the beginning of the first visit. Results showed that the slope of dwell time decreased with levodopa but not with placebo (P = 0.004). The rate of force decline also decreased with levodopa but not with placebo (P = 0.01). The subscores in the dimension of physical fatigue in the MFI did not correlate with the rate changes in dwell time or the rate changes in force decline. We concluded that (1) levodopa improves physical fatigue in finger tapping and force generation, (2) physical fatigue in Parkinson's disease is at least partially related to dopamine deficiency, and (3) the MFI measures different aspects of physical fatigue compared with those measured by finger tapping and force generation.

KW - Finger tapping

KW - Force generation

KW - MFI

KW - MIDI

KW - Parkinson's disease

KW - Physical fatigue

UR - http://www.scopus.com/inward/record.url?scp=0242288106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242288106&partnerID=8YFLogxK

U2 - 10.1002/mds.10505

DO - 10.1002/mds.10505

M3 - Article

C2 - 14534913

AN - SCOPUS:0242288106

VL - 18

SP - 1108

EP - 1114

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 10

ER -